Archive - February 2022
COVID-19 Omicron Subvariant Presents 2 New Symptoms: Report
FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease
Merck KGaA’s Glucophage approved in Europe as first oral diabetic medication for use during pregnancy
Pushing health boundaries in space and manufacturing
Sanofi and Regeneron announce positive phase 3 trial results for Dupixent
CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients
Neglected rare disease patients offered hope in new plan
Do Outdated COVID Restrictions Contribute to The Mental Health Crisis?